# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE:CL) with a Overweight and raises the price target fr...
Michael Burry, famous for predicting 2008 crisis, made headlines with his latest 13F filing. He shifted towards commodities &am...
Argus Research analyst Chris Graja maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $97 to ...
Cannabis producer Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) announced on Wednesday its financial and operating resul...
Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahas...
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from...
Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and raises the price target from $...